Murepavadin Terminated Phase 3 Trials for Pneumonia Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03582007Pivotal Study in Nosocomial Pneumonia Suspected or Confirmed to be Due to Pseudomonas
NCT03409679Pivotal Study in VAP Suspected or Confirmed to be Due to Pseudomonas Aeruginosa